My lab is developing (i) novel cancer therapeutics based on the normal signaling of the epithelial-stromal program and (ii) computational methods for identifying biomarkers of tumor heterogeneity.
My lab is developing (i) novel cancer therapeutics based on the normal signaling of the epithelial-stromal program and (ii) computational methods for identifying biomarkers of tumor heterogeneity.